TP53BP1 and cervical cancer: Moreover, increased expression levels of TP53BP1 and MCM9 and decreased expression levels of POLR2F and SIRT6 were found to be specifically associated with a poorer prognosis for HPV18+ (but not HPV16+) cervical cancer patients following PRT.